Understanding the impact of opioid agonist treatment in reducing crime

August 2019
In a recently published study, we examined the link between opioid agonist treatment (OAT) and crime in nearly 11,000 people in New South Wales (NSW).
Read more
June 2019

Beyond ‘pill testing’: Calling for appropriate event health care services at music festivals

Professor Simon Lenton, NDRI
April 2019

Why focusing on the AOD workforce is important

Dr Natalie Skinner, Senior Research Fellow, NCETA
February 2019

How is Australia responding to the pharmaceutical opioid problem?

Dr Gabrielle Campbell, NHMRC Australian Public Health Early Career Fellow at NDARC, UNSW.
December 2018

Cannabis regulation: Profit versus public health

Professor Simon Lenton, Director, NDRI
October 2018

Clinical practice guidelines: Questions of relevance, reliability and utility explored

Professor Ann Roche, Director, NCETA
August 2018

Can we improve processes for engaging communities and services in research?

Professor Anthony Shakeshaft, National Drug and Alcohol Research Centre, UNSW Sydney
June 2018

Renewed interest in psychedelics as potentially useful therapeutic agents

NDRI Adjunct Research Fellow Dr Stephen Bright shares his views about psychedelic research programs that have been initiated by several prestigious in
May 2018

Wastewater analysis - what does it mean for AOD policy and practice?

Ann Roche, Director & Allan Trifonoff, Deputy Director (Programs), NCETA
March 2018

To reduce child injury deaths in Australia we need to look at the link to adult alcohol consumption

Dr Anne-Marie Laslett, Senior Research Fellow, NDRI
December 2017

Health economics is not just about measuring costs

Dr Marian Shanahan, NDARC

Pages